#TumorBoardTuesday Rana McKay Mike Pishvaian paramveer singh antony ruggeri Minas Economides, MD Erica M. Román, MD Prostate Cancer UK Prostate Cancer Foundation ZERO - The End of Prostate Cancer 2/4 #TumorBoardTuesday
Thurs Case🎀

Take🏠mgs:
#prostatecancer & DNA damage repair mutations
✅Send NGS (somatic & germline) in mCRPC
✅PARPi ⬆️effective w biallelic loss
✅Key SEs= ⬇️🩸&🤢

📚We captured Rana McKay’s discussion in this moment: twitter.com/i/events/15796…

#TumorBoardTuesday Rana McKay Mike Pishvaian paramveer singh antony ruggeri Minas Economides, MD Erica M. Román, MD Prostate Cancer UK Prostate Cancer Foundation ZERO - The End of Prostate Cancer 3/4 #TumorBoardTuesday
Thursday Case🎀

📷 TBT in an image:
Take a look at a (simplified) guide to management of metastatic castration resistant prostate cancer (mCRPC) and PARPi data in DDR mutated disease.

Don’t forget about PARPi side effect mgmt either!

#TumorBoardTuesday Rana McKay Mike Pishvaian paramveer singh antony ruggeri Minas Economides, MD Erica M. Román, MD Prostate Cancer UK Prostate Cancer Foundation ZERO - The End of Prostate Cancer Eric K. Singhi, MD Jacob J. Adashek, DO 4/4 #TumorBoardTuesday

#TumorBoardTuesday
Thursday Case🎀

🙏 Germline NGS is 🔑 in mCRPC
🤔 Earlier PARPi (ARSI + PARPi for BRCAm) in the future?

➡️Please be sure to join us on 10/18/22 when Eleonora Teplinsky, MD discusses key considerations in
early-stage HER2+ breast cancer! #BC

Johnathan Ebben MD, PhD Rana McKay Mike Pishvaian paramveer singh antony ruggeri Minas Economides, MD Erica M. Román, MD Prostate Cancer UK Prostate Cancer Foundation ZERO - The End of Prostate Cancer Eric K. Singhi, MD Jacob J. Adashek, DO Eleonora Teplinsky, MD Remember #TumorBoardTuesday continues to offer AMA & MOC credit for FREE! Don’t forget to answer the polls👇🏽
Then click this link to quickly request your credit!
CME eval🔗: integrityce.com/tbteval
ALL CME 🔗: integrityce.com/tbt

Johnathan Ebben MD, PhD Rana McKay Mike Pishvaian paramveer singh antony ruggeri Minas Economides, MD Erica M. Román, MD Prostate Cancer UK Prostate Cancer Foundation ZERO - The End of Prostate Cancer Eric K. Singhi, MD Jacob J. Adashek, DO Eleonora Teplinsky, MD #PostTest Q1️⃣ #CME #TumorBoardTuesday
👉🏽CME Eval 🔗 integrityce.com/tbtEval
👉🏽ALL CME🔗 integrityce.com/tbt

🤔Rana McKay taught us🧬biomarker testing in #prostatecancer , test your🧠with 2⃣quick❓

🧐Which of the following HRR🧬gene-mutations qualify for olaparib therapy❓

Johnathan Ebben MD, PhD Rana McKay Mike Pishvaian paramveer singh antony ruggeri Minas Economides, MD Erica M. Román, MD Prostate Cancer UK Prostate Cancer Foundation ZERO - The End of Prostate Cancer Eric K. Singhi, MD Jacob J. Adashek, DO Eleonora Teplinsky, MD #PostTest Q2️⃣ #CME #TumorBoardTuesday
Free CME🔗: integrityce.com/tbt

🧐Which of the following is an FDA approved✅companion diagnostic🔬for olaparib for mCRPC❓

Nice going Mike Pishvaian

I'm so looking forward to this!!

📢GI Oncology Friends and Colleagues‼️
#OncTwitter #GIOncology

😀I am so excited to announce our inagural Johns Hopkins Johns Hopkins Kimmel Cancer Center 'Updates in GI Cancers Conference'

✅SAVE THE DATE🗓️February 3rd and 4th, 2023

👉More info to come & There will be a virtual🖥️option!

📢Hopkins Updates in GI Cancers
🗓️Feb 3&4 2023
Johns Hopkins Kimmel Cancer Center Integrity CE SoMe CME #TumorBoardTuesday

🧑‍🏫Amazing speakers
Vivek Subbiah, MD John Marshall Dr. Dr. Helene Andrews-Polymenis Dr. Nina Niu Sanford Dr. Neeha Zaidi Mark Yarchoan Timothy M. Pawlik Sunnie Kim, MD ILSON David Matthew HG Katz, MD Tanios Bekaii-Saab, MD Jin He Pamela Kunz, MD Marina Baretti

What do you want to know about early stage HER2+? Let us know! #TumorBoardTuesday

Rana McKay Johnathan Ebben MD, PhD Jennifer Marks, MD #TumorBoardTuesday #TumorBoardTuesday

🙏Thank you Rana McKay for🚶‍♀️us through a case of BRCA-mutated #prostatecancer

And please join us next week, 10/18/22, as Eleonora Teplinsky, MD 🧑‍🏫us about Early-stage HER2+ #BreastCancer

Johnathan Ebben MD, PhD Rana McKay #TumorBoardTuesday #TumorBoardTuesday

The original NEJM article on olaparib for DDR-mutated prostate cancer was amazing!

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer pubmed.ncbi.nlm.nih.gov/26510020/

Mike Pishvaian Rana McKay Johnathan Ebben MD, PhD #TumorBoardTuesday Sure, but not all the pts tumor cells are small cell. Biopsy and ctDNA markers would help